Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.
Luminal breast cancer
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen
/wp-content
The proportion of breast cancer receptors and subtypes. ER+
Breast Cancer: Practice Essentials, Background, Anatomy
Androgen and oestrogen receptor co-expression determines the
Updates in endocrine therapy for metastatic breast cancer
Proteogenomic Landscape of Breast Cancer Tumorigenesis and
Silencing growth hormone receptor inhibits estrogen receptor
Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive
An emerging generation of endocrine therapies in breast cancer: a
Breast Cancer: Practice Essentials, Background, Anatomy
Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer
